MedTrace Logo

Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

NCT04082351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 387

Last updated 2019-09-10

No results posted yet for this study

Summary

Type 2 DM is due to insulin resistance or low insulin secretion or sometimes a combination of both. Nanotechnology structured water is a type of water that is produced using energy field modulators to change the biological, chemical, and physical properties of water molecules and improve the bioavailability of this nano-water. Objective: To find out the effect of drinking nanotechnology structured water (Magnalife®) on the blood glucose levels in patients with type 2 diabetes mellitus.

Conditions

  • Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Nanotechnology structured water ( Magnalife)

Nanotechnology structured water ( Magnalife), is given as dietary supplement to the patients to drink it according to their weight .

DIETARY_SUPPLEMENT

ordinary water

Ordinary bottled water

Sponsors & Collaborators

  • ALI KAMAL M. SAMI

    lead OTHER

Principal Investigators

  • Ali K M.Sami, Ph.D. · College of Medicine, University of Sulaimani

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-03
Primary Completion
2018-02-16
Completion
2018-02-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082351 on ClinicalTrials.gov